{"id":193186,"date":"2021-04-19T16:10:52","date_gmt":"2021-04-19T16:10:52","guid":{"rendered":"https:\/\/bm.dev.synology.me\/?p=193186"},"modified":"2026-04-08T11:02:44","modified_gmt":"2026-04-08T11:02:44","slug":"italia-ia-in-calcul-producerea-locala-a-vaccinurilor-anti-covid-pe-baza-de-arn-mesager","status":"publish","type":"post","link":"https:\/\/bm.dev.synology.me\/?p=193186","title":{"rendered":"Italia ia \u00een calcul producerea local\u0103 a vaccinurilor anti-COVID pe baz\u0103 de ARN mesager"},"content":{"rendered":"<p>\nAutorit\u0103\u0163ile italiene iau \u00een considerare producerea local\u0103 a vaccinurilor anti-coronavirus pe baz\u0103 de ARN mesager.<\/p>\n<p>\nRoma a discutat p\u00e2n\u0103 acum cu firma american\u0103 de biotehnologie Moderna, grupul elve\u0163ian Novartis \u015fi compania italian\u0103 ReiThera, conform unor persoane familiare cu situa\u0163ia, citate de Financial Times, conform ZF.<\/p>\n<p>\nNegocierile cu Novartis \u015fi ReiThera au inclus posibilitatea producerii vaccinului ARN mesager dezvoltat de firma german\u0103 CureVac \u00een Italia.<\/p>\n<p>\n\u00cen martie, Novartis a semnat un acord ini\u0163ial cu grupul CureVac pentru a produce o parte din vaccinurile anti-COVID-19 ale companiei. Serul se afl\u0103 \u00een faza a treia a testelor clinice, \u00eens\u0103 compania cu sediul \u00een T\u00fcbingen a declarat c\u0103 sper\u0103 ca vaccinul s\u0103 fie aprobat \u00een UE \u00een mai sau iunie.<\/p>\n<p>\nMomentan, ReiThera lucreaz\u0103 la un vaccin pe baz\u0103 de adenoviru\u015fi, aflat \u00eens\u0103 \u00een a doua faz\u0103 a testelor clinice.<\/p>\n<p>\nMario Draghi, prim-ministrul Italiei, a vorbit direct cu CEO-ul Moderna St\u00e9phane Bancel, \u00eens\u0103 discu\u0163iile au e\u015fuat \u00eentruc\u00e2t compania american\u0103 nu dispune de capacitatea necesar\u0103 transfer\u0103rii tehnologiei c\u0103tre fabricile italiene.<\/p>\n<p>\nAnterior, Moderna a subliniat lipsa staff-ului calificat drept una dintre principalele bariere din procesele de producere ale vaccinurilor anti-coronavirus.<\/p>\n<p>\nEforturile italienilor de a accelera producerea dozelor bazate pe ARN mesager, tehnologie prin care se transmit informa\u0163ii despre \u00eenveli\u015ful virusului pe care sistemul imunitar s\u0103 \u00eel poat\u0103 identifica ulterior, vin pe m\u0103sur\u0103 ce UE pare s\u0103 se distan\u0163eze de vaccinurilor bazate pe adenoviru\u015fi, dezvoltate de AstraZeneca \u015fi Johnson &amp; Johnson.<\/p>\n<p>\n\u201eTrebuie s\u0103 ne concentr\u0103m asupra tehnologiilor care \u015fi-au dovedit valoarea. Vaccinurile ARN mesager reprezint\u0103 un caz foarte clar\u201d, spune pre\u015fedintele Comisiei Europene, Ursula vor der Leyen. Bruxellesul discut\u0103 deja cu BioNTech\/Pfizer, care produce unul dintre principalele ARN mesager, \u00eentr-un acord de 1,8 miliarde de doze p\u00e2n\u0103 \u00een 2022-2023.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Autorit\u0103\u0163ile italiene iau \u00een considerare producerea local\u0103 a vaccinurilor anti-coronavirus pe baz\u0103 de ARN mesager. Roma a discutat p\u00e2n\u0103 acum cu firma american\u0103 de biotehnologie Moderna, grupul elve\u0163ian Novartis \u015fi compania italian\u0103 ReiThera.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[7507,14848],"class_list":["post-193186","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-italia","tag-vaccinuri"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/193186","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=193186"}],"version-history":[{"count":1,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/193186\/revisions"}],"predecessor-version":[{"id":193214,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/193186\/revisions\/193214"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=193186"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=193186"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=193186"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}